ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antibacterial Vaccines Market Research Report 2024
Published Date: June 2024
|
Report Code: QYRE-Auto-8D17588
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Antibacterial Vaccines Market Research Report 2024
BUY CHAPTERS

Global Antibacterial Vaccines Market Research Report 2024

Code: QYRE-Auto-8D17588
Report
June 2024
Pages:103
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Emergent BioDefense Operations Lansing Inc
Sanofi Pasteur
Merck
MedImmune
Novartis Vaccines
Diagnostics Ltd
Intercell Biomedical
MassBiologics
Barr Labs Inc
Organon Teknika Co
GlaxoSmithKline Biologicals
CSL Limited
ID Biomedical Co
Protein Sciences Co
Wyeth Pharmaceuticals Inc
Berna Biotech

Antibacterial Vaccines Market

Antibacterial vaccines are a type of immunization that targets bacteria to prevent or reduce the severity of bacterial infections. While vaccines are typically associated with the prevention of viral infections, there are also vaccines that can protect against bacterial diseases.
The global Antibacterial Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Antibacterial Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Antibacterial Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Antibacterial Vaccines include Emergent BioDefense Operations Lansing Inc., Sanofi Pasteur, Merck & Co., MedImmune LLC, Novartis Vaccines, Diagnostics Ltd., Intercell Biomedical, MassBiologics, Barr Labs, Inc., Organon Teknika Co., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antibacterial Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibacterial Vaccines.
The Antibacterial Vaccines market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Antibacterial Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibacterial Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Antibacterial Vaccines Market Report

Report Metric Details
Report Name Antibacterial Vaccines Market
Segment by Type
  • Inactivated Vaccines
  • Conjugate Vaccines
  • Live/attenuated Vaccines
Segment by Application
  • Bacterial Diseases
  • Viral Diseases
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Emergent BioDefense Operations Lansing Inc., Sanofi Pasteur, Merck & Co., MedImmune LLC, Novartis Vaccines, Diagnostics Ltd., Intercell Biomedical, MassBiologics, Barr Labs, Inc., Organon Teknika Co., GlaxoSmithKline Biologicals, CSL Ltd., ID Biomedical Co., Protein Sciences Co., Wyeth Pharmaceuticals, Inc., Berna Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Antibacterial Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Antibacterial Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Antibacterial Vaccines Market report?

Ans: The main players in the Antibacterial Vaccines Market are Emergent BioDefense Operations Lansing Inc., Sanofi Pasteur, Merck & Co., MedImmune LLC, Novartis Vaccines, Diagnostics Ltd., Intercell Biomedical, MassBiologics, Barr Labs, Inc., Organon Teknika Co., GlaxoSmithKline Biologicals, CSL Ltd., ID Biomedical Co., Protein Sciences Co., Wyeth Pharmaceuticals, Inc., Berna Biotech

What are the Application segmentation covered in the Antibacterial Vaccines Market report?

Ans: The Applications covered in the Antibacterial Vaccines Market report are Bacterial Diseases, Viral Diseases

What are the Type segmentation covered in the Antibacterial Vaccines Market report?

Ans: The Types covered in the Antibacterial Vaccines Market report are Inactivated Vaccines, Conjugate Vaccines, Live/attenuated Vaccines

1 Antibacterial Vaccines Market Overview
1.1 Product Definition
1.2 Antibacterial Vaccines by Type
1.2.1 Global Antibacterial Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Inactivated Vaccines
1.2.3 Conjugate Vaccines
1.2.4 Live/attenuated Vaccines
1.3 Antibacterial Vaccines by Application
1.3.1 Global Antibacterial Vaccines Market Value by Application (2024-2030)
1.3.2 Bacterial Diseases
1.3.3 Viral Diseases
1.4 Global Antibacterial Vaccines Market Size Estimates and Forecasts
1.4.1 Global Antibacterial Vaccines Revenue 2019-2030
1.4.2 Global Antibacterial Vaccines Sales 2019-2030
1.4.3 Global Antibacterial Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Antibacterial Vaccines Market Competition by Manufacturers
2.1 Global Antibacterial Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Antibacterial Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Antibacterial Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Antibacterial Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Antibacterial Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antibacterial Vaccines, Product Type & Application
2.7 Global Key Manufacturers of Antibacterial Vaccines, Date of Enter into This Industry
2.8 Global Antibacterial Vaccines Market Competitive Situation and Trends
2.8.1 Global Antibacterial Vaccines Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Antibacterial Vaccines Players Market Share by Revenue
2.8.3 Global Antibacterial Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Antibacterial Vaccines Market Scenario by Region
3.1 Global Antibacterial Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Antibacterial Vaccines Sales by Region: 2019-2030
3.2.1 Global Antibacterial Vaccines Sales by Region: 2019-2024
3.2.2 Global Antibacterial Vaccines Sales by Region: 2025-2030
3.3 Global Antibacterial Vaccines Revenue by Region: 2019-2030
3.3.1 Global Antibacterial Vaccines Revenue by Region: 2019-2024
3.3.2 Global Antibacterial Vaccines Revenue by Region: 2025-2030
3.4 North America Antibacterial Vaccines Market Facts & Figures by Country
3.4.1 North America Antibacterial Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Antibacterial Vaccines Sales by Country (2019-2030)
3.4.3 North America Antibacterial Vaccines Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Antibacterial Vaccines Market Facts & Figures by Country
3.5.1 Europe Antibacterial Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Antibacterial Vaccines Sales by Country (2019-2030)
3.5.3 Europe Antibacterial Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antibacterial Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Antibacterial Vaccines Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Antibacterial Vaccines Sales by Region (2019-2030)
3.6.3 Asia Pacific Antibacterial Vaccines Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Antibacterial Vaccines Market Facts & Figures by Country
3.7.1 Latin America Antibacterial Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Antibacterial Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Antibacterial Vaccines Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Antibacterial Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Antibacterial Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Antibacterial Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Antibacterial Vaccines Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Antibacterial Vaccines Sales by Type (2019-2030)
4.1.1 Global Antibacterial Vaccines Sales by Type (2019-2024)
4.1.2 Global Antibacterial Vaccines Sales by Type (2025-2030)
4.1.3 Global Antibacterial Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Antibacterial Vaccines Revenue by Type (2019-2030)
4.2.1 Global Antibacterial Vaccines Revenue by Type (2019-2024)
4.2.2 Global Antibacterial Vaccines Revenue by Type (2025-2030)
4.2.3 Global Antibacterial Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Antibacterial Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Antibacterial Vaccines Sales by Application (2019-2030)
5.1.1 Global Antibacterial Vaccines Sales by Application (2019-2024)
5.1.2 Global Antibacterial Vaccines Sales by Application (2025-2030)
5.1.3 Global Antibacterial Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Antibacterial Vaccines Revenue by Application (2019-2030)
5.2.1 Global Antibacterial Vaccines Revenue by Application (2019-2024)
5.2.2 Global Antibacterial Vaccines Revenue by Application (2025-2030)
5.2.3 Global Antibacterial Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Antibacterial Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Emergent BioDefense Operations Lansing Inc.
6.1.1 Emergent BioDefense Operations Lansing Inc. Company Information
6.1.2 Emergent BioDefense Operations Lansing Inc. Description and Business Overview
6.1.3 Emergent BioDefense Operations Lansing Inc. Antibacterial Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Emergent BioDefense Operations Lansing Inc. Antibacterial Vaccines Product Portfolio
6.1.5 Emergent BioDefense Operations Lansing Inc. Recent Developments/Updates
6.2 Sanofi Pasteur
6.2.1 Sanofi Pasteur Company Information
6.2.2 Sanofi Pasteur Description and Business Overview
6.2.3 Sanofi Pasteur Antibacterial Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi Pasteur Antibacterial Vaccines Product Portfolio
6.2.5 Sanofi Pasteur Recent Developments/Updates
6.3 Merck & Co.
6.3.1 Merck & Co. Company Information
6.3.2 Merck & Co. Description and Business Overview
6.3.3 Merck & Co. Antibacterial Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck & Co. Antibacterial Vaccines Product Portfolio
6.3.5 Merck & Co. Recent Developments/Updates
6.4 MedImmune LLC
6.4.1 MedImmune LLC Company Information
6.4.2 MedImmune LLC Description and Business Overview
6.4.3 MedImmune LLC Antibacterial Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 MedImmune LLC Antibacterial Vaccines Product Portfolio
6.4.5 MedImmune LLC Recent Developments/Updates
6.5 Novartis Vaccines
6.5.1 Novartis Vaccines Company Information
6.5.2 Novartis Vaccines Description and Business Overview
6.5.3 Novartis Vaccines Antibacterial Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Novartis Vaccines Antibacterial Vaccines Product Portfolio
6.5.5 Novartis Vaccines Recent Developments/Updates
6.6 Diagnostics Ltd.
6.6.1 Diagnostics Ltd. Company Information
6.6.2 Diagnostics Ltd. Description and Business Overview
6.6.3 Diagnostics Ltd. Antibacterial Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Diagnostics Ltd. Antibacterial Vaccines Product Portfolio
6.6.5 Diagnostics Ltd. Recent Developments/Updates
6.7 Intercell Biomedical
6.7.1 Intercell Biomedical Company Information
6.7.2 Intercell Biomedical Description and Business Overview
6.7.3 Intercell Biomedical Antibacterial Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Intercell Biomedical Antibacterial Vaccines Product Portfolio
6.7.5 Intercell Biomedical Recent Developments/Updates
6.8 MassBiologics
6.8.1 MassBiologics Company Information
6.8.2 MassBiologics Description and Business Overview
6.8.3 MassBiologics Antibacterial Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 MassBiologics Antibacterial Vaccines Product Portfolio
6.8.5 MassBiologics Recent Developments/Updates
6.9 Barr Labs, Inc.
6.9.1 Barr Labs, Inc. Company Information
6.9.2 Barr Labs, Inc. Description and Business Overview
6.9.3 Barr Labs, Inc. Antibacterial Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Barr Labs, Inc. Antibacterial Vaccines Product Portfolio
6.9.5 Barr Labs, Inc. Recent Developments/Updates
6.10 Organon Teknika Co.
6.10.1 Organon Teknika Co. Company Information
6.10.2 Organon Teknika Co. Description and Business Overview
6.10.3 Organon Teknika Co. Antibacterial Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Organon Teknika Co. Antibacterial Vaccines Product Portfolio
6.10.5 Organon Teknika Co. Recent Developments/Updates
6.11 GlaxoSmithKline Biologicals
6.11.1 GlaxoSmithKline Biologicals Company Information
6.11.2 GlaxoSmithKline Biologicals Description and Business Overview
6.11.3 GlaxoSmithKline Biologicals Antibacterial Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.11.4 GlaxoSmithKline Biologicals Antibacterial Vaccines Product Portfolio
6.11.5 GlaxoSmithKline Biologicals Recent Developments/Updates
6.12 CSL Ltd.
6.12.1 CSL Ltd. Company Information
6.12.2 CSL Ltd. Description and Business Overview
6.12.3 CSL Ltd. Antibacterial Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.12.4 CSL Ltd. Antibacterial Vaccines Product Portfolio
6.12.5 CSL Ltd. Recent Developments/Updates
6.13 ID Biomedical Co.
6.13.1 ID Biomedical Co. Company Information
6.13.2 ID Biomedical Co. Description and Business Overview
6.13.3 ID Biomedical Co. Antibacterial Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.13.4 ID Biomedical Co. Antibacterial Vaccines Product Portfolio
6.13.5 ID Biomedical Co. Recent Developments/Updates
6.14 Protein Sciences Co.
6.14.1 Protein Sciences Co. Company Information
6.14.2 Protein Sciences Co. Description and Business Overview
6.14.3 Protein Sciences Co. Antibacterial Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Protein Sciences Co. Antibacterial Vaccines Product Portfolio
6.14.5 Protein Sciences Co. Recent Developments/Updates
6.15 Wyeth Pharmaceuticals, Inc.
6.15.1 Wyeth Pharmaceuticals, Inc. Company Information
6.15.2 Wyeth Pharmaceuticals, Inc. Description and Business Overview
6.15.3 Wyeth Pharmaceuticals, Inc. Antibacterial Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Wyeth Pharmaceuticals, Inc. Antibacterial Vaccines Product Portfolio
6.15.5 Wyeth Pharmaceuticals, Inc. Recent Developments/Updates
6.16 Berna Biotech
6.16.1 Berna Biotech Company Information
6.16.2 Berna Biotech Description and Business Overview
6.16.3 Berna Biotech Antibacterial Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Berna Biotech Antibacterial Vaccines Product Portfolio
6.16.5 Berna Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antibacterial Vaccines Industry Chain Analysis
7.2 Antibacterial Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antibacterial Vaccines Production Mode & Process
7.4 Antibacterial Vaccines Sales and Marketing
7.4.1 Antibacterial Vaccines Sales Channels
7.4.2 Antibacterial Vaccines Distributors
7.5 Antibacterial Vaccines Customers
8 Antibacterial Vaccines Market Dynamics
8.1 Antibacterial Vaccines Industry Trends
8.2 Antibacterial Vaccines Market Drivers
8.3 Antibacterial Vaccines Market Challenges
8.4 Antibacterial Vaccines Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Emergent BioDefense Operations Lansing Inc
Sanofi Pasteur
Merck
MedImmune
Novartis Vaccines
Diagnostics Ltd
Intercell Biomedical
MassBiologics
Barr Labs Inc
Organon Teknika Co
GlaxoSmithKline Biologicals
CSL Limited
ID Biomedical Co
Protein Sciences Co
Wyeth Pharmaceuticals Inc
Berna Biotech
List of Tables
 Table 1. Global Antibacterial Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Antibacterial Vaccines Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Antibacterial Vaccines Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Antibacterial Vaccines Sales (Units) of Key Manufacturers (2019-2024)
 Table 5. Global Antibacterial Vaccines Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Antibacterial Vaccines Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Antibacterial Vaccines Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Antibacterial Vaccines Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Antibacterial Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Antibacterial Vaccines, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Antibacterial Vaccines, Product Type & Application
 Table 12. Global Key Manufacturers of Antibacterial Vaccines, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Antibacterial Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibacterial Vaccines as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Antibacterial Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Antibacterial Vaccines Sales by Region (2019-2024) & (Units)
 Table 18. Global Antibacterial Vaccines Sales Market Share by Region (2019-2024)
 Table 19. Global Antibacterial Vaccines Sales by Region (2025-2030) & (Units)
 Table 20. Global Antibacterial Vaccines Sales Market Share by Region (2025-2030)
 Table 21. Global Antibacterial Vaccines Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Antibacterial Vaccines Revenue Market Share by Region (2019-2024)
 Table 23. Global Antibacterial Vaccines Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Antibacterial Vaccines Revenue Market Share by Region (2025-2030)
 Table 25. North America Antibacterial Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Antibacterial Vaccines Sales by Country (2019-2024) & (Units)
 Table 27. North America Antibacterial Vaccines Sales by Country (2025-2030) & (Units)
 Table 28. North America Antibacterial Vaccines Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Antibacterial Vaccines Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Antibacterial Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Antibacterial Vaccines Sales by Country (2019-2024) & (Units)
 Table 32. Europe Antibacterial Vaccines Sales by Country (2025-2030) & (Units)
 Table 33. Europe Antibacterial Vaccines Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Antibacterial Vaccines Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Antibacterial Vaccines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Antibacterial Vaccines Sales by Region (2019-2024) & (Units)
 Table 37. Asia Pacific Antibacterial Vaccines Sales by Region (2025-2030) & (Units)
 Table 38. Asia Pacific Antibacterial Vaccines Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Antibacterial Vaccines Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Antibacterial Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Antibacterial Vaccines Sales by Country (2019-2024) & (Units)
 Table 42. Latin America Antibacterial Vaccines Sales by Country (2025-2030) & (Units)
 Table 43. Latin America Antibacterial Vaccines Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Antibacterial Vaccines Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Antibacterial Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Antibacterial Vaccines Sales by Country (2019-2024) & (Units)
 Table 47. Middle East and Africa Antibacterial Vaccines Sales by Country (2025-2030) & (Units)
 Table 48. Middle East and Africa Antibacterial Vaccines Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Antibacterial Vaccines Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Antibacterial Vaccines Sales (Units) by Type (2019-2024)
 Table 51. Global Antibacterial Vaccines Sales (Units) by Type (2025-2030)
 Table 52. Global Antibacterial Vaccines Sales Market Share by Type (2019-2024)
 Table 53. Global Antibacterial Vaccines Sales Market Share by Type (2025-2030)
 Table 54. Global Antibacterial Vaccines Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Antibacterial Vaccines Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Antibacterial Vaccines Revenue Market Share by Type (2019-2024)
 Table 57. Global Antibacterial Vaccines Revenue Market Share by Type (2025-2030)
 Table 58. Global Antibacterial Vaccines Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Antibacterial Vaccines Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Antibacterial Vaccines Sales (Units) by Application (2019-2024)
 Table 61. Global Antibacterial Vaccines Sales (Units) by Application (2025-2030)
 Table 62. Global Antibacterial Vaccines Sales Market Share by Application (2019-2024)
 Table 63. Global Antibacterial Vaccines Sales Market Share by Application (2025-2030)
 Table 64. Global Antibacterial Vaccines Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Antibacterial Vaccines Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Antibacterial Vaccines Revenue Market Share by Application (2019-2024)
 Table 67. Global Antibacterial Vaccines Revenue Market Share by Application (2025-2030)
 Table 68. Global Antibacterial Vaccines Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Antibacterial Vaccines Price (US$/Unit) by Application (2025-2030)
 Table 70. Emergent BioDefense Operations Lansing Inc. Company Information
 Table 71. Emergent BioDefense Operations Lansing Inc. Description and Business Overview
 Table 72. Emergent BioDefense Operations Lansing Inc. Antibacterial Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Emergent BioDefense Operations Lansing Inc. Antibacterial Vaccines Product
 Table 74. Emergent BioDefense Operations Lansing Inc. Recent Developments/Updates
 Table 75. Sanofi Pasteur Company Information
 Table 76. Sanofi Pasteur Description and Business Overview
 Table 77. Sanofi Pasteur Antibacterial Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Sanofi Pasteur Antibacterial Vaccines Product
 Table 79. Sanofi Pasteur Recent Developments/Updates
 Table 80. Merck & Co. Company Information
 Table 81. Merck & Co. Description and Business Overview
 Table 82. Merck & Co. Antibacterial Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Merck & Co. Antibacterial Vaccines Product
 Table 84. Merck & Co. Recent Developments/Updates
 Table 85. MedImmune LLC Company Information
 Table 86. MedImmune LLC Description and Business Overview
 Table 87. MedImmune LLC Antibacterial Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. MedImmune LLC Antibacterial Vaccines Product
 Table 89. MedImmune LLC Recent Developments/Updates
 Table 90. Novartis Vaccines Company Information
 Table 91. Novartis Vaccines Description and Business Overview
 Table 92. Novartis Vaccines Antibacterial Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Novartis Vaccines Antibacterial Vaccines Product
 Table 94. Novartis Vaccines Recent Developments/Updates
 Table 95. Diagnostics Ltd. Company Information
 Table 96. Diagnostics Ltd. Description and Business Overview
 Table 97. Diagnostics Ltd. Antibacterial Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Diagnostics Ltd. Antibacterial Vaccines Product
 Table 99. Diagnostics Ltd. Recent Developments/Updates
 Table 100. Intercell Biomedical Company Information
 Table 101. Intercell Biomedical Description and Business Overview
 Table 102. Intercell Biomedical Antibacterial Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Intercell Biomedical Antibacterial Vaccines Product
 Table 104. Intercell Biomedical Recent Developments/Updates
 Table 105. MassBiologics Company Information
 Table 106. MassBiologics Description and Business Overview
 Table 107. MassBiologics Antibacterial Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. MassBiologics Antibacterial Vaccines Product
 Table 109. MassBiologics Recent Developments/Updates
 Table 110. Barr Labs, Inc. Company Information
 Table 111. Barr Labs, Inc. Description and Business Overview
 Table 112. Barr Labs, Inc. Antibacterial Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Barr Labs, Inc. Antibacterial Vaccines Product
 Table 114. Barr Labs, Inc. Recent Developments/Updates
 Table 115. Organon Teknika Co. Company Information
 Table 116. Organon Teknika Co. Description and Business Overview
 Table 117. Organon Teknika Co. Antibacterial Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Organon Teknika Co. Antibacterial Vaccines Product
 Table 119. Organon Teknika Co. Recent Developments/Updates
 Table 120. GlaxoSmithKline Biologicals Company Information
 Table 121. GlaxoSmithKline Biologicals Description and Business Overview
 Table 122. GlaxoSmithKline Biologicals Antibacterial Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. GlaxoSmithKline Biologicals Antibacterial Vaccines Product
 Table 124. GlaxoSmithKline Biologicals Recent Developments/Updates
 Table 125. CSL Ltd. Company Information
 Table 126. CSL Ltd. Description and Business Overview
 Table 127. CSL Ltd. Antibacterial Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 128. CSL Ltd. Antibacterial Vaccines Product
 Table 129. CSL Ltd. Recent Developments/Updates
 Table 130. ID Biomedical Co. Company Information
 Table 131. ID Biomedical Co. Description and Business Overview
 Table 132. ID Biomedical Co. Antibacterial Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 133. ID Biomedical Co. Antibacterial Vaccines Product
 Table 134. ID Biomedical Co. Recent Developments/Updates
 Table 135. Protein Sciences Co. Company Information
 Table 136. Protein Sciences Co. Description and Business Overview
 Table 137. Protein Sciences Co. Antibacterial Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 138. Protein Sciences Co. Antibacterial Vaccines Product
 Table 139. Protein Sciences Co. Recent Developments/Updates
 Table 140. Wyeth Pharmaceuticals, Inc. Company Information
 Table 141. Wyeth Pharmaceuticals, Inc. Description and Business Overview
 Table 142. Wyeth Pharmaceuticals, Inc. Antibacterial Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 143. Wyeth Pharmaceuticals, Inc. Antibacterial Vaccines Product
 Table 144. Wyeth Pharmaceuticals, Inc. Recent Developments/Updates
 Table 145. Berna Biotech Company Information
 Table 146. Berna Biotech Description and Business Overview
 Table 147. Berna Biotech Antibacterial Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 148. Berna Biotech Antibacterial Vaccines Product
 Table 149. Berna Biotech Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Antibacterial Vaccines Distributors List
 Table 153. Antibacterial Vaccines Customers List
 Table 154. Antibacterial Vaccines Market Trends
 Table 155. Antibacterial Vaccines Market Drivers
 Table 156. Antibacterial Vaccines Market Challenges
 Table 157. Antibacterial Vaccines Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Antibacterial Vaccines
 Figure 2. Global Antibacterial Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Antibacterial Vaccines Market Share by Type: 2023 & 2030
 Figure 4. Inactivated Vaccines Product Picture
 Figure 5. Conjugate Vaccines Product Picture
 Figure 6. Live/attenuated Vaccines Product Picture
 Figure 7. Global Antibacterial Vaccines Market Value by Application (2024-2030) & (US$ Million)
 Figure 8. Global Antibacterial Vaccines Market Share by Application: 2023 & 2030
 Figure 9. Bacterial Diseases
 Figure 10. Viral Diseases
 Figure 11. Global Antibacterial Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 12. Global Antibacterial Vaccines Market Size (2019-2030) & (US$ Million)
 Figure 13. Global Antibacterial Vaccines Sales (2019-2030) & (Units)
 Figure 14. Global Antibacterial Vaccines Average Price (US$/Unit) & (2019-2030)
 Figure 15. Antibacterial Vaccines Report Years Considered
 Figure 16. Antibacterial Vaccines Sales Share by Manufacturers in 2023
 Figure 17. Global Antibacterial Vaccines Revenue Share by Manufacturers in 2023
 Figure 18. Global 5 and 10 Largest Antibacterial Vaccines Players: Market Share by Revenue in Antibacterial Vaccines in 2023
 Figure 19. Antibacterial Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 20. Global Antibacterial Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 21. North America Antibacterial Vaccines Sales Market Share by Country (2019-2030)
 Figure 22. North America Antibacterial Vaccines Revenue Market Share by Country (2019-2030)
 Figure 23. United States Antibacterial Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Canada Antibacterial Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Europe Antibacterial Vaccines Sales Market Share by Country (2019-2030)
 Figure 26. Europe Antibacterial Vaccines Revenue Market Share by Country (2019-2030)
 Figure 27. Germany Antibacterial Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. France Antibacterial Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. U.K. Antibacterial Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Italy Antibacterial Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Russia Antibacterial Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Asia Pacific Antibacterial Vaccines Sales Market Share by Region (2019-2030)
 Figure 33. Asia Pacific Antibacterial Vaccines Revenue Market Share by Region (2019-2030)
 Figure 34. China Antibacterial Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Japan Antibacterial Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. South Korea Antibacterial Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. India Antibacterial Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Australia Antibacterial Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. China Taiwan Antibacterial Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Southeast Asia Antibacterial Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Latin America Antibacterial Vaccines Sales Market Share by Country (2019-2030)
 Figure 42. Mexico Antibacterial Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Brazil Antibacterial Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Argentina Antibacterial Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Colombia Antibacterial Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Middle East and Africa Antibacterial Vaccines Sales Market Share by Country (2019-2030)
 Figure 47. Middle East and Africa Antibacterial Vaccines Revenue Market Share by Country (2019-2030)
 Figure 48. Turkey Antibacterial Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Saudi Arabia Antibacterial Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. UAE Antibacterial Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Global Sales Market Share of Antibacterial Vaccines by Type (2019-2030)
 Figure 52. Global Revenue Market Share of Antibacterial Vaccines by Type (2019-2030)
 Figure 53. Global Antibacterial Vaccines Price (US$/Unit) by Type (2019-2030)
 Figure 54. Global Sales Market Share of Antibacterial Vaccines by Application (2019-2030)
 Figure 55. Global Revenue Market Share of Antibacterial Vaccines by Application (2019-2030)
 Figure 56. Global Antibacterial Vaccines Price (US$/Unit) by Application (2019-2030)
 Figure 57. Antibacterial Vaccines Value Chain
 Figure 58. Antibacterial Vaccines Production Process
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Bacterial Vaccines for Humans Market Research Report 2024
Global Antibacterial Masks Market Insights Forecast to 2030
Veterinary Vaccine Market
Global Antibacterial Bandages Market Research Report 2024
Global Diphtheria Vaccines Market Research Report 2024
Pneumococcal Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Veterinary Vaccination Market Research Report 2025
Global Pediatric Antibiotics Market Research Report 2024
Global Pneumococcal Vaccination Market Research Report 2025
Global Livestock Animal Vaccines Market Research Report 2024
Global Antibacterial Clothing Market Research Report 2024
Global Veterinary Biological Vaccines Market Research Report 2025
Global Bacille Calmette Guerin Vaccine Market Research Report 2024
Global Antibacterial Filter Market Research Report 2024
Pneumococcal Bacteria Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Disease Control and Prevention Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global TB Disease Vaccine Market Research Report 2025
Global Preventive Vaccines Market Insights Forecast to 2030
Global TB Vaccines Market Insights Forecast to 2030
Global BCG Vaccine for Tuberculosis TB Market Research Report 2025

RELATED REPORTS

Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21N6899
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13M6952
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29X7355
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28B293
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions